MedTrace Logo

Clinical Trial of Abluminus DES+ Sirolimus Eluting Stent Versus Everolimus-eluting DES

NCT03399994 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 137

Last updated 2022-07-27

No results posted yet for this study

Summary

The objective of the study is to compare angiographic and clinical performance of Abluminus DES+ versus Everolimus-eluting DES in patients with diabetes mellitus.

Conditions

Interventions

DEVICE

device implantation during coronary angioplasty

device implantation during coronary angioplasty

Sponsors & Collaborators

  • Mediolanum Cardio Research

    collaborator OTHER

  • Fondazione Evidence per Attività e Ricerche Cardiovascolari ONLUS

    lead OTHER

Principal Investigators

  • Antonio Colombo, MD · Ospedale San Raffaele

  • Azeem Latib, MD · Ospedale San Raffaele

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-21
Primary Completion
2021-04-15
Completion
2022-07-26

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03399994 on ClinicalTrials.gov